Literature DB >> 7449584

Relationship between cerebrospinal fluid norepinephrine and blood pressure in neurologic patients.

M G Ziegler, C R Lake, J H Wood, B R Brooks.   

Abstract

In 126 patients hospitalized for various diseases norepinephrine in cerebrospinal fluid correlated with blood pressure (r = 0.41, p < 0.0001). Plasma and cerebrospinal fluid norepinephrine levels correlated with heart rate. Central noradrenergic nerves help control blood pressure and may be involved in human hypertension.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7449584     DOI: 10.3109/10641968009037157

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 0148-3927            Impact factor:   1.749


  6 in total

1.  Alteration in autonomic function and cardiovascular regulation in amyotrophic lateral sclerosis.

Authors:  K Chida; S Sakamaki; T Takasu
Journal:  J Neurol       Date:  1989-03       Impact factor: 4.849

2.  Microneurographic analysis of muscle sympathetic nerve activity in amyotrophic lateral sclerosis.

Authors:  K Shindo; S Tsunoda; Z Shiozawa
Journal:  Clin Auton Res       Date:  1993-04       Impact factor: 4.435

Review 3.  Central nervous system norepinephrine metabolism in hypertension.

Authors:  G W Lambert
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

4.  CSF sulfoconjugated catecholamines in man: their relationship with plasma catecholamines.

Authors:  O Kuchel; C Hausser; N T Buu; S Tenneson
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

5.  The relationship of free and conjugated catecholamines in plasma and cerebrospinal fluid in cerebral and meningeal disease.

Authors:  D Ratge; W Bauersfeld; H Wisser
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

6.  Cardiac sympathetic function in the patients with amyotrophic lateral sclerosis: analysis using cardiac [123I] MIBG scintigraphy.

Authors:  Yuji Tanaka; Megumi Yamada; Akihiro Koumura; Takeo Sakurai; Yuichi Hayashi; Akio Kimura; Isao Hozumi; Takashi Inuzuka
Journal:  J Neurol       Date:  2013-06-20       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.